Αυτή η ανάρτηση είναι από μια προτεινόμενη ομάδα
Critical Care Adjuncts: Market Drivers and Therapeutic Applications for the Thiamine Hydrochloride Injection Market
The Thiamine Hydrochloride Injection Market is a specialized, yet essential, segment within hospital and acute care pharmacy, with the market size estimated at USD 182.01 million in 2025 and forecasted for steady growth. Injectable thiamine, or Vitamin B1, is a vital component for treating and preventing acute thiamine deficiency, which can lead to serious conditions like wet beriberi and, most critically, Wernicke-Korsakoff syndrome (WKS)—a severe neurological disorder that currently accounts for the largest indication share of the market. Beyond this primary indication, the market is experiencing significant growth momentum from the increasing adoption of injectable thiamine as a crucial adjunct therapy in septic shock and sepsis bundles. Clinical research has demonstrated that a significant percentage of Intensive Care Unit (ICU) patients present with sub-clinical thiamine depletion, and protocolized supplementation has been shown to optimize lactate clearance…